克罗恩病与溃疡性结肠炎：从病理生理学到新型治疗方法
Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches.
作者信息
Long Dingpei
机构信息
State Key Laboratory of Resource Insects, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400715, China.
Institute for Biomedical Sciences, Center for Inflammation, Immunity & Infection, Digestive Disease Research Group, Georgia State University, Atlanta, GA 30303, USA.
出版信息
Biomedicines. 2024 Mar 19;12(3):689. doi: 10.3390/biomedicines12030689.
Abstract
Inflammatory bowel disease (IBD) is a non-specific autoimmune condition impacting the gastrointestinal tract, encompassing Crohn's disease (CD) and ulcerative colitis (UC) [...].
摘要
炎症性肠病（IBD）是一种影响胃肠道的非特异性自身免疫性疾病，包括克罗恩病（CD）和溃疡性结肠炎（UC）[...]。
相似文献
1
Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches.克罗恩病与溃疡性结肠炎：从病理生理学到新型治疗方法
Biomedicines. 2024 Mar 19;12(3):689. doi: 10.3390/biomedicines12030689.
2
Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.患者对吸烟与炎症性肠病的看法：与欧洲克罗恩病和溃疡性结肠炎协会合作开展的在线调查
World J Gastroenterol. 2020 Aug 7;26(29):4343-4355. doi: 10.3748/wjg.v26.i29.4343.
3
Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.与溃疡性结肠炎相比，克罗恩病是非酒精性脂肪性肝病的更大风险因素：一项系统评价。
Cureus. 2023 Aug 5;15(8):e42995. doi: 10.7759/cureus.42995. eCollection 2023 Aug.
4
The MYTHS of Crohn's Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis.溃疡性结肠炎行回肠储袋肛管吻合术式的全直肠系膜切除术后克罗恩病的误区
Jpn J Gastroenterol Hepatol. 2020;3(2). Epub 2020 Mar 11.
5
Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.两样本孟德尔随机化分析探究肠道微生物属与炎症性肠病之间的因果关联，以及溃疡性结肠炎或克罗恩病中特定的因果关联。
Front Immunol. 2022 Jul 4;13:921546. doi: 10.3389/fimmu.2022.921546. eCollection 2022.
6
Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.罗德岛州克罗恩病和溃疡性结肠炎的发病率：来自海洋州克罗恩病和结肠炎区域登记处的报告。
Inflamm Bowel Dis. 2016 Jun;22(6):1456-61. doi: 10.1097/MIB.0000000000000745.
7
Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.孤立性克罗恩结肠炎：定位至关重要吗？来自CEDATA - GPGE注册中心的儿科患者特征
Front Pediatr. 2022 May 31;10:875938. doi: 10.3389/fped.2022.875938. eCollection 2022.
8
Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.睡眠障碍与克罗恩病和溃疡性结肠炎患者活动期疾病的风险。
Clin Gastroenterol Hepatol. 2013 Aug;11(8):965-71. doi: 10.1016/j.cgh.2013.01.021. Epub 2013 Feb 1.
9
Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis.克罗恩病和溃疡性结肠炎粪便样本的代谢组学研究。
J Proteomics. 2019 Jun 15;201:93-103. doi: 10.1016/j.jprot.2019.04.009. Epub 2019 Apr 19.
10
Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.50 年来英国卡迪夫炎症性肠病发病和临床特征的变化：2005-2016 年更新。
Scand J Gastroenterol. 2023 Jun;58(6):619-626. doi: 10.1080/00365521.2022.2158754. Epub 2022 Dec 23.
引用本文的文献
1
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel Disease.迈向精准医学：炎症性肠病中对托法替布反应的分子生物标志物
Genes (Basel). 2025 Jul 29;16(8):908. doi: 10.3390/genes16080908.
2
Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems.基于蛋白质的纳米颗粒药物递送系统在炎症性肠病口服治疗中的进展。
Drug Deliv. 2025 Dec;32(1):2544689. doi: 10.1080/10717544.2025.2544689. Epub 2025 Aug 11.
3
Protective effects of dill fruit against acute acetic acid-induced ulcerative colitis by reducing inflammation and oxidative stress in rats.莳萝果实通过减轻大鼠炎症和氧化应激对急性乙酸诱导的溃疡性结肠炎的保护作用。
Physiol Rep. 2025 May;13(10):e70393. doi: 10.14814/phy2.70393.
4
p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway.对羟基苯甲醛通过激活HNF-1β/SLC26A3途径减轻结肠炎引起的肠上皮屏障功能障碍。
Front Pharmacol. 2024 Nov 22;15:1448863. doi: 10.3389/fphar.2024.1448863. eCollection 2024.
5
Establishment and Characterization of Patient-Derived Intestinal Organoids from Pediatric Crohn's Disease Patients.来自儿童克罗恩病患者的患者源性肠道类器官的建立与表征
Pediatr Gastroenterol Hepatol Nutr. 2024 Nov;27(6):355-363. doi: 10.5223/pghn.2024.27.6.355. Epub 2024 Nov 5.
6
Abdominal Pain in Inflammatory Bowel Disease-Epidemiology, Pathophysiology, and Management: A Narrative Review.炎症性肠病中的腹痛——流行病学、病理生理学及管理：一项叙述性综述
Pain Ther. 2024 Dec;13(6):1447-1469. doi: 10.1007/s40122-024-00672-9. Epub 2024 Oct 28.
本文引用的文献
1
Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab.质子泵抑制剂的联合使用可能会对接受维得利珠单抗治疗的炎症性肠病的疗效产生负面影响。
Biomedicines. 2024 Jan 11;12(1):158. doi: 10.3390/biomedicines12010158.
2
The Impact of Obesity on Inflammatory Bowel Disease.肥胖对炎症性肠病的影响。
Biomedicines. 2023 Dec 8;11(12):3256. doi: 10.3390/biomedicines11123256.
3
Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing.炎症性肠病疾病活动度评估：组织学愈合评估中的诊断工具
Biomedicines. 2023 Nov 18;11(11):3090. doi: 10.3390/biomedicines11113090.
4
Prevalence of Fibromyalgia and Chronic Fatigue Syndrome among Individuals with Irritable Bowel Syndrome: An Analysis of United States National Inpatient Sample Database.肠易激综合征患者中纤维肌痛和慢性疲劳综合征的患病率：对美国国家住院样本数据库的分析
Biomedicines. 2023 Sep 22;11(10):2594. doi: 10.3390/biomedicines11102594.
5
Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study.甲氨蝶呤联合英夫利昔单抗初始治疗小儿克罗恩病的疗效：一项初步研究。
Biomedicines. 2023 Sep 19;11(9):2575. doi: 10.3390/biomedicines11092575.
6
Novel Approach in Rectovaginal Fistula Treatment: Combination of Modified Martius Flap and Autologous Micro-Fragmented Adipose Tissue.直肠阴道瘘治疗的新方法：改良马蒂厄皮瓣与自体微片段脂肪组织联合应用
Biomedicines. 2023 Sep 11;11(9):2509. doi: 10.3390/biomedicines11092509.
7
Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies.炎症性肠病：新兴疗法与未来治疗策略
Biomedicines. 2023 Aug 11;11(8):2249. doi: 10.3390/biomedicines11082249.
8
Endogenous Opioids in Crohn's Disease.克罗恩病中的内源性阿片类物质
Biomedicines. 2023 Jul 20;11(7):2037. doi: 10.3390/biomedicines11072037.
9
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice.口服负载M13的纳米脂质体对治疗小鼠结肠炎相关癌症是安全有效的。
Expert Opin Drug Deliv. 2023 Jul-Dec;20(10):1443-1462. doi: 10.1080/17425247.2023.2231345. Epub 2023 Jul 2.
10
Prophylactic vs. Therapeutic Effect of Probiotics on the Inflammation Mediated by the NF-κB Pathway in Inflammatory Bowel Conditions.益生菌对炎症性肠病中由NF-κB途径介导的炎症的预防作用与治疗作用
Biomedicines. 2023 Jun 9;11(6):1675. doi: 10.3390/biomedicines11061675.
Zotero 插件